The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial
about
Glycemic Targets in Diabetes Care: Emerging Clarity after AccordMetrics for glycaemic control - from HbA1c to continuous glucose monitoring.Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial.Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 Diabetes.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysisHemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes.Considerations on glycaemic control in older and/or frail individuals with diabetes and advanced kidney disease.The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality.HbA1c for type 2 diabetes diagnosis in Africans and African Americans: Personalized medicine NOW!Factors associated with failure to achieve a glycated haemoglobin target of <8.0% in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study.Response to comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial.Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.Glucose challenge test screening for prediabetes and early diabetes.The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.Microvascular Parameters Help to Predict Stroke Risk in the Asian Diabetic Population in Taiwan: A Population Based Case-Control Study
P2860
Q26795380-0EFDDD8E-4A8C-4BB2-90D1-55B6E2098410Q30252932-062A5F8D-0B75-4A79-B3FE-B72A7D2C77EAQ30276113-68453874-DD31-4F55-84AD-EA3CFB426F9CQ30278367-77B6BF17-9682-43AA-999E-59E964D29713Q33584606-817CBD6C-2FC0-4981-86A1-90C8684B32F9Q35782729-3E41F4E8-91EB-4799-9850-F279F3D3B50EQ36275557-3A8B2181-8D84-4C58-961B-6DD019D8C166Q36820609-F7818265-B3A9-41E7-A58E-4D1F1981068BQ38878430-8A3D41D4-786D-4A64-942F-7DA9994BFA44Q38967759-0116D6CB-3D1D-4146-BC7C-0DCBCD5B5904Q40023042-E23C0C5D-2DC5-453B-B912-4957E012520FQ40045609-91B3F57E-D978-44C6-924A-6BAE54410A9AQ40468686-C7DF922C-4A02-4FD7-B773-2A6C07A1ACD2Q42270747-53648CD6-0C33-4312-A491-DCE1DE8F1C3FQ42769132-0E55A21F-3360-4B90-ADB8-CD5C47FD656DQ47148809-57E84277-3844-441B-AFA3-221ECE60F629Q47172963-16796DF7-F7B3-4DB4-8AC6-6483007F1957Q47199486-21734FFD-0EFF-4CE5-86DE-7A8CF08C007AQ48037494-E014AD4C-B2C5-4771-A8BB-DACD6419486DQ48364304-24731954-F8B6-4260-A033-6B8CDB13AF3DQ58694087-BCB74E71-761D-4797-AE29-BBAD66FA7F53
P2860
The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The hemoglobin glycation index ...... treatment in the ACCORD trial
@ast
The hemoglobin glycation index ...... treatment in the ACCORD trial
@en
type
label
The hemoglobin glycation index ...... treatment in the ACCORD trial
@ast
The hemoglobin glycation index ...... treatment in the ACCORD trial
@en
prefLabel
The hemoglobin glycation index ...... treatment in the ACCORD trial
@ast
The hemoglobin glycation index ...... treatment in the ACCORD trial
@en
P2093
P2860
P356
P1433
P1476
The hemoglobin glycation index ...... treatment in the ACCORD trial
@en
P2093
Leann Myers
Robert J McCarter
Shuqian Liu
Vivian Fonseca
P2860
P304
P356
10.2337/DC14-1844
P407
P577
2015-04-17T00:00:00Z